Cryo-Cell International Inc. (NYSEAMERICAN:CCEL – Get Free Report)’s stock price traded down 10.2% during mid-day trading on Friday. The stock traded as low as $4.34 and last traded at $4.85. Approximately 14,208 shares traded hands during trading, an increase of 68% from the average daily volume of 8,440 shares. The stock had previously closed at $5.40.
Cryo-Cell International Price Performance
The stock has a fifty day moving average price of $4.47 and a 200 day moving average price of $3.76. The stock has a market capitalization of $39.09 million, a P/E ratio of -21.09 and a beta of 0.45.
Cryo-Cell International (NYSEAMERICAN:CCEL – Get Free Report) last released its quarterly earnings data on Friday, October 9th. The company reported $0.16 earnings per share (EPS) for the quarter. The company had revenue of $7.82 million for the quarter.
Hedge Funds Weigh In On Cryo-Cell International
A hedge fund recently raised its position in Cryo-Cell International stock. Susquehanna International Group LLP grew its position in shares of Cryo-Cell International Inc. (NYSEAMERICAN:CCEL – Free Report) by 40.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,064 shares of the company’s stock after purchasing an additional 4,046 shares during the period. Susquehanna International Group LLP owned approximately 0.17% of Cryo-Cell International worth $45,000 at the end of the most recent quarter. 10.44% of the stock is currently owned by hedge funds and other institutional investors.
Cryo-Cell International Company Profile
Cryo-Cell International provides stem cell processing and cryogenic storage services, primarily for families preserving cells collected at childbirth. Its core services include processing and storing umbilical cord blood and cord tissue for potential future medical use. Founded in 1989, the company is based in Oldsmar, Florida, and is among the early private cord blood banking businesses in the United States. It serves customers in the U.S. and reaches international markets through distribution relationships.
Further Reading
- Five stocks we like better than Cryo-Cell International
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Cryo-Cell International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryo-Cell International and related companies with MarketBeat.com's FREE daily email newsletter.
